Addus HomeCare (NASDAQ:ADUS – Get Free Report) and Progyny (NASDAQ:PGNY – Get Free Report) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, dividends, valuation, analyst recommendations and profitability.
Profitability
This table compares Addus HomeCare and Progyny’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Addus HomeCare | 7.39% | 10.22% | 8.01% |
| Progyny | 6.80% | 19.82% | 12.75% |
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Addus HomeCare and Progyny, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Addus HomeCare | 1 | 2 | 8 | 1 | 2.75 |
| Progyny | 0 | 4 | 11 | 0 | 2.73 |
Volatility & Risk
Addus HomeCare has a beta of 0.75, meaning that its share price is 25% less volatile than the S&P 500. Comparatively, Progyny has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.
Valuation and Earnings
This table compares Addus HomeCare and Progyny”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Addus HomeCare | $1.42 billion | 1.59 | $95.91 million | $6.00 | 20.18 |
| Progyny | $1.29 billion | 2.03 | $58.52 million | $1.09 | 32.52 |
Addus HomeCare has higher revenue and earnings than Progyny. Addus HomeCare is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
95.3% of Addus HomeCare shares are owned by institutional investors. Comparatively, 94.9% of Progyny shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by company insiders. Comparatively, 9.9% of Progyny shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Addus HomeCare beats Progyny on 8 of the 15 factors compared between the two stocks.
About Addus HomeCare
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
About Progyny
Progyny, Inc. provides fertility and family-building benefits to employers and their employees. Its services are designed to help members navigate care options, access fertility specialists and receive support throughout treatment. The company’s offerings include coverage for treatments such as in vitro fertilization and egg freezing, along with fertility medications through its pharmacy benefit. Progyny also supports other family-building paths, including adoption and surrogacy, depending on the plan selected by an employer.
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
